Cambridge, MA – According to filings with the U.S. Securities and Exchange Commission, PepGen is raising $112,499,887.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, James McArthur played a key…
Cambridge, MA – According to filings with the U.S. Securities and Exchange Commission, Iterative Scopes is raising $32,065,161.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Jonathan Ng played a…
Cambridge, MA – According to filings with the U.S. Securities and Exchange Commission, Strand Therapeutics is raising $52,143,967.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Jacob Becraft played a…
Cambridge, MA – According to filings with the U.S. Securities and Exchange Commission, Spero Therapeutics is raising $39,999,985.00 in new funding. Sources indicate as part of senior management Chief Financial Officer, Sath Shukla played a…
Cambridge, MA – According to filings with the U.S. Securities and Exchange Commission, Molten is raising $6,996,427.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Arjun Mendhi played a key…
Cambridge, MA – According to filings with the U.S. Securities and Exchange Commission, Ennoventure is raising $5,645,000.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Padmakumar Nair played a key…
Cambridge, MA – According to filings with the U.S. Securities and Exchange Commission, Metrika is raising $17,676,887.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Nikos Adrikogiannopoulos played a key…
Cambridge, MA – According to filings with the U.S. Securities and Exchange Commission, Glympse Bio is raising $46,699,979.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Caroline Loew played a…
Cambridge, MA – According to filings with the U.S. Securities and Exchange Commission, Abata Therapeutics is raising $95,000,000.00 in new funding. Sources indicate as part of senior management President and Chief Executive Officer, Samantha Singer…
Cambridge, MA – According to filings with the U.S. Securities and Exchange Commission, Ribon Therapeutics is raising $60,150,139.00 in new funding. Sources indicate as part of senior management President and Chief Executive Officer, Victoria Richon…